These findings suggest that the reduced T1D incidence with decreased splenocyte-iDL signaling is associated with mitigated insulitis and preservation of β-cells and is independent of differences in splenic CD4+ or CD8+ T-cell abundances and activation. This evidence concerns the gene CD4 and type 1 diabetes mellitus.